Diabetes cell therapy (Qurgen)

N/A

Report date: 2025/04/21 16:57:15

Base Information

Drug NameDiabetes cell therapy (Qurgen)
Drug Alias NameREPROGRABETES
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionPancreatic beta cell replacements
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesQurgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesQurgen Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A